
See our Facebook feed without logging in to Facebook!

Follow our Twitter feed of news and more!
|
|
May 23, 2011
The orphan tyrosine kinase LMTK3 has been identified as a potential biomarker of response to endocrine therapy in patients with breast cancer, as well as a possible new therapeutic target. Scientists claim the protein plays a key role in regulating estrogen receptor α (ERα) activity; in breast cancer patients high nuclear LMTK3 [...]
If you’ve walked in a Susan G. Komen 3-Day For The Cure breast cancer walk before, you are well aware of the joy, the pain, the blisters, dehydration, friends, crew and all the ups and downs of walking 60 miles. One of the best parts and motivating factors to get back back to camp is [...]
Study Shows Chemotherapy and Hormonal Therapy May Affect Balance of Patients
March 4, 2011 – Breast cancer treatments such as chemotherapyand hormonal therapy may affect the patients’ balance, increasing their risk of falls, a new study shows.
Researchers at the Oregon Health and Science University Knight Cancer Institute studied 59 postmenopausal breast cancer survivors who had received treatment [...]
Original post: February 7, 2011
The youngest known survivor of breast cancer is Aleisha Hunter from Ontario, Canada. At only three years old, Aleisha underwent a complete mastectomy in 2010 to treat her juvenile strain of breast cancer.k Breast cancer is the most common type of cancer among American women after skin cancer. It is [...]
|
Spread the Word Click here to get code for adding the Continue Kim's Fight button to your MySpace page, web page, or email signature.
*
Continue Kim's Fight is not affiliated with, or licensed by, the Breast Cancer 3-Day for the cure, or its beneficiaries Susan G. Komen for the Cure. No donations are made directly to CKF but instead to the aforementioned foundations.
|